Back to Search Start Over

Investigation of parasite genetic variation and systemic immune responses in patients presenting with different clinical presentations of cutaneous leishmaniasis caused by Leishmania aethiopica.

Authors :
Yizengaw, Endalew
Takele, Yegnasew
Franssen, Susanne
Gashaw, Bizuayehu
Yimer, Mulat
Adem, Emebet
Nibret, Endalkachew
Yismaw, Gizachew
Cruz Cervera, Edward
Ejigu, Kefale
Tamiru, Dessalegn
Munshea, Abaineh
Müller, Ingrid
Weller, Richard
Cotton, James A.
Kropf, Pascale
Source :
Infectious Diseases of Poverty. 10/16/2024, Vol. 13 Issue 1, p1-14. 14p.
Publication Year :
2024

Abstract

Background: Cutaneous leishmaniasis (CL) is a neglected tropical skin disease, caused by the protozoan parasite Leishmania. In Ethiopia, CL is mainly caused by Leishmania aethiopica and can present in different clinical forms. The aim of this study was to assess whether these different forms are associated with differences in parasite genetic and host systemic immune signatures. Methods: Here we analysed the whole genome sequence data for 48 clinical parasite isolates and the systemic immune signature from a cohort of CL patients, who were recruited in Nefas Mewcha, Northern Ethiopia, from January 2019 to January 2022. Results: Our results show that parasites from CL cases with different presentations in a single Ethiopian setting are from the same genetic population based on a permutation test of genome-wide similarity. Furthermore, a logistic regression test for genome wide association did not identify any individual genetic variants significantly associated with disease presentation. We also measured plasma chemokine and cytokine levels of 129 CL patients presenting with different forms of CL. None of the chemokine [eotaxin, eotaxin-3, interleukin (IL)-8, interferon (IFN)-γ-induced protein-10 (IP-10), monocyte chemoattractant protein (MCP)-1, MCP-4, macrophage-derived chemokines (MDC), macrophage inflammatory protein (MIP)-1α, MIP-1β and thymus- and activation-regulated chemokine (TARC)] or cytokine (IFN-γ, IL-1β, interleukin-2, IL-4, IL-6, IL-10, IL-12p70, IL-13, tumor necrosis factor-α) levels measured were significantly different between the different clinical presentations of CL, as measured by Kruskal–Wallis test. We also compared those with healthy nonendemic controls: our results show a chemokine (IP-10, MCP-1, MCP-4, MDC, MIP-1α, MIP-1β and TARC) but not a cytokine immune signature in patients with CL as compared to healthy nonendemic controls, as measured by Mann-Whitney test. Conclusions: The results of our study did not identify a systemic immune signature or parasite genetic factors associated with different clinical presentation of CL. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20499957
Volume :
13
Issue :
1
Database :
Academic Search Index
Journal :
Infectious Diseases of Poverty
Publication Type :
Academic Journal
Accession number :
180331369
Full Text :
https://doi.org/10.1186/s40249-024-01244-x